These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33710134)

  • 1. Stereotactic Body Radiotherapy for Palliation of Hematuria Arising From Urothelial Carcinoma of the Kidney in Unfavorable Surgical Candidates.
    Aronowitz J; Ding L; Yates J; Zong Y; Zheng L; Jiang Z; Yancey J; Mittal K; Fitzgerald TJ
    Am J Clin Oncol; 2021 May; 44(5):175-180. PubMed ID: 33710134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal safety and efficacy of cisplatin-based chemotherapy in patients with a solitary kidney after nephroureterectomy for urothelial carcinoma of the upper urinary tract.
    Cho KS; Joung JY; Seo HK; Cho IC; Chung HS; Chung J; Lee KH
    Cancer Chemother Pharmacol; 2011 Apr; 67(4):769-74. PubMed ID: 20532510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of transitional cell carcinoma on multidetector computerized tomography urography in patients with gross hematuria.
    Wang LJ; Wong YC; Chuang CK; Huang CC; Pang ST
    J Urol; 2009 Feb; 181(2):524-31; discussion 531. PubMed ID: 19100576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of preoperative renal function and gross hematuria for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.
    Hashimoto T; Nakashima J; Kashima T; Hirasawa Y; Shimodaira K; Gondo T; Nakagami Y; Namiki K; Horiguchi Y; Ohno Y; Ohori M; Tachibana M
    Int J Urol; 2017 Feb; 24(2):111-116. PubMed ID: 27875859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma.
    Williams AK; Kassouf W; Chin J; Rendon R; Jacobsen N; Fairey A; Kapoor A; Black P; Lacombe L; Tanguay S; So A; Lattouf JB; Bell D; Fradet Y; Saad F; Matsumoto E; Drachenberg D; Cagiannos I; Izawa JI
    Urol Oncol; 2013 Oct; 31(7):1161-5. PubMed ID: 23415596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience.
    Francolini G; Desideri I; Detti B; Di Cataldo V; Masi L; Caramia G; Visani L; Terziani F; Muntoni C; Lo Russo M; Loi M; Livi L
    Cancer Treat Res Commun; 2019; 19():100124. PubMed ID: 30851645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors and treatment outcomes of new contralateral upper urinary urothelial carcinoma after nephroureterectomy: the experiences of a large Chinese center.
    Fang D; Zhang L; Li X; Xiong G; Chen X; Han W; He Z; Zhou L
    J Cancer Res Clin Oncol; 2014 Mar; 140(3):477-85. PubMed ID: 24469253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent urothelial carcinoma in the renal pelvis of an allograft kidney and native recipient bladder: evidence of donor origin.
    Takaoka E; Miyazaki J; Kimura T; Kojima T; Kawai K; Murata Y; Itoguchi N; Minami Y; Nakamura T; Honda K; Nishiyama H
    Jpn J Clin Oncol; 2014 Apr; 44(4):366-9. PubMed ID: 24596334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience.
    Cutress ML; Stewart GD; Tudor EC; Egong EA; Wells-Cole S; Phipps S; Thomas BG; Riddick AC; McNeill SA; Tolley DA
    J Urol; 2013 Jun; 189(6):2054-60. PubMed ID: 23228378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?
    Marvaso G; Corrao G; Oneta O; Pepa M; Zaffaroni M; Corso F; Gandini S; Cecconi A; Zerini D; Mazzola GC; Augugliaro M; Cossu Rocca M; Verri E; Cattani F; La Fauci F; Bergamaschi L; Luzzago S; Mistretta AF; Musi G; Nolè F; De Cobelli O; Orecchia R; Jereczek-Fossa BA
    Clin Transl Oncol; 2021 Aug; 23(8):1717-1726. PubMed ID: 33687659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
    Aboumohamed AA; Krane LS; Hemal AK
    J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reassessment of prognostic heterogeneity of pT3 renal pelvic urothelial carcinoma: analysis in terms of proposed pT3 subclassification systems.
    Park J; Habuchi T; Arai Y; Ohyama C; Inoue T; Hatakeyama S; Jeon SS; Kwon GY; Kwak C; Moon KC; Kim CS; Ahn H
    J Urol; 2014 Oct; 192(4):1064-71. PubMed ID: 24735938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery.
    Thalmann GN; Markwalder R; Walter B; Studer UE
    J Urol; 2002 Oct; 168(4 Pt 1):1381-5. PubMed ID: 12352398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synchronous renal carcinoma and urothelioma of the contralateral renal pelvis].
    Ronchetti E; Fava G; Dossena G; Rolandi P; Lo Re V; Fibbi ML
    Minerva Chir; 1999 May; 54(5):359-62. PubMed ID: 10443118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single fraction radiosurgery for the treatment of renal tumors.
    Staehler M; Bader M; Schlenker B; Casuscelli J; Karl A; Roosen A; Stief CG; Bex A; Wowra B; Muacevic A
    J Urol; 2015 Mar; 193(3):771-5. PubMed ID: 25132240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic Body Radiotherapy for Stage I Renal Cell Carcinoma: National Treatment Trends and Outcomes Compared to Partial Nephrectomy and Thermal Ablation.
    Uhlig A; Uhlig J; Trojan L; Kim HS
    J Vasc Interv Radiol; 2020 Apr; 31(4):564-571. PubMed ID: 32127324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative predictors of renal function decline after radical nephroureterectomy for upper tract urothelial carcinoma.
    Kaag M; Trost L; Thompson RH; Favaretto R; Elliott V; Shariat SF; Maschino A; Vertosick E; Raman JD; Dalbagni G
    BJU Int; 2014 Nov; 114(5):674-9. PubMed ID: 24314050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of local radiotherapy on metastatic urothelial carcinoma patients receiving systemic chemotherapy.
    Abe T; Minami K; Harabayashi T; Sazawa A; Chiba H; Kikuchi H; Miyata H; Frumido J; Matsumoto R; Osawa T; Junji I; Tango M; Satoshi C; Tomoshige A; Masashi M; Naoto M; Kunihiko T; Satoru M; Murai S; Shinohara N
    Jpn J Clin Oncol; 2020 Feb; 50(2):206-213. PubMed ID: 31665467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urothelial-cell carcinoma and solitary kidney: outcomes with renal-sparing management.
    Milner JE; Voelzke BB; Flanigan RC; Sharma SK; Perry KT; Turk TM
    J Endourol; 2006 Oct; 20(10):800-7. PubMed ID: 17094758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermediate-term oncological outcomes of hand-assisted laparoscopic versus open bilateral nephroureterectomy for dialysis and kidney transplant patients with upper urinary tract urothelial carcinoma.
    Tai HC; Lai MK; Chung SD; Huang KH; Chueh SC; Yu HJ
    J Endourol; 2009 Jul; 23(7):1139-44. PubMed ID: 19530901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.